Partner Content Partner Content 3 things you should know about ADaM standards Digging deeper into the Analysis Data Model (ADaM)
Partner Content Partner Content Using SDTM, ADaM, and SEND for Regulatory Submissions Using SDTM, ADaM, and SEND for Regulatory Submissions
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
